• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Vicarious Surgical Inc. (Amendment)

    2/13/24 4:36:42 PM ET
    $RBOT
    Industrial Specialties
    Health Care
    Get the next $RBOT alert in real time by email
    SC 13G/A 1 tm245599d1_sc13ga.htm SC 13G/A

     

     

     

      UNITED STATES  
      SECURITIES AND EXCHANGE COMMISSION  
      Washington, D.C. 20549  
         

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*

     

    Vicarious Surgical Inc.

    (Name of Issuer)

     

    Class A Common Stock, $0.0001 par value

    (Title of Class of Securities)

     

    92561V109

    (CUSIP Number)

     

    December 31, 2023

     

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    o Rule 13d-1(b)
    ý Rule 13d-1(c)
    o Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

    CUSIP No. 92561V109
      1. Names of Reporting Persons
    Gates Frontier, LLC
     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) o
        (b) o
     
      3. SEC Use Only
     
      4. Citizenship or Place of Organization
    State of Washington
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    18,096,043 (1) 
     
    6. Shared Voting Power
    -0-
     
    7. Sole Dispositive Power
    18,096,043 (1) 
     
    8. Shared Dispositive Power
    -0-
     
      9. Aggregate Amount Beneficially Owned by Each Reporting Person
    18,096,043 (1) 
     
      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
     
      11. Percent of Class Represented by Amount in Row (9)
    11.7% (2) 
     
      12. Type of Reporting Person (See Instructions)
    OO
               

     

     

    (1) All shares of the Class A common stock, $0.0001 par value per share (the “Class A Common Stock”), of Vicarious Surgical Inc. (the “Issuer”) held by Gates Frontier, LLC (“GF”) may be deemed to be beneficially owned by William H. Gates III as the sole member of GF.

     

    (2) Based on 155,269,690 shares of Class A Common Stock outstanding as of October 18, 2023, as reported on the Issuer’s Form 10-Q filed on November 13, 2023.

     

     

     

    CUSIP No. 92561V109
      1. Names of Reporting Persons
    William H. Gates III
     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) o
        (b) o
     
      3. SEC Use Only
     
      4. Citizenship or Place of Organization
    United States of America
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    18,096,043 (1) 
     
    6. Shared Voting Power
    -0-
     
    7. Sole Dispositive Power
    18,096,043 (1) 
     
    8. Shared Dispositive Power
    -0-
     
      9. Aggregate Amount Beneficially Owned by Each Reporting Person
    18,096,043 (1) 
     
      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o
     
      11. Percent of Class Represented by Amount in Row (9)
    11.7% (2) 
     
      12. Type of Reporting Person (See Instructions)
    IN
               

     

     

    (1) All shares of the Class A Common Stock of the Issuer held by GF may be deemed to be beneficially owned by William H. Gates III as the sole member of GF.

     

    (2) Based on 155,269,690 shares of Class A Common Stock outstanding as of October 18, 2023, as reported on the Issuer’s Form 10-Q filed on November 13, 2023.

     

     

     

    Item 1.
      (a) Name of Issuer:
    Vicarious Surgical Inc. (the “Issuer”)
      (b)

    Address of Issuer’s Principal Executive Offices:
    78 Fourth Avenue
    Waltham, Massachusetts 02451

     
    Item 2.
      (a) Name of Person Filing:
    Gates Frontier, LLC (“GF”) and William H. Gates III (“WHG”, and together with GF, the “Reporting Persons”)
      (b)

    Address of Principal Business Office or, if none, Residence:
    GF – 2365 Carillon Point, Kirkland, Washington 98033

    WHG – 500 Fifth Avenue North, Seattle, Washington 98109

      (c)

    Citizenship:
    GF is a limited liability company organized under the laws of the State of Washington.

    WHG is a citizen of the United States of America.

      (d) Title of Class of Securities:
    Class A common Stock, $0.0001 par value per share
      (e)

    CUSIP Number:

    92561V109

     
    Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
      Not Applicable.
     
    Item 4. Ownership.
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
      (a)

    Amount beneficially owned:   

    See the responses to Item 9 on the attached cover pages.

      (b)

    Percent of class:   

    See the responses to Item 11 on the attached cover pages.

      (c) Number of shares as to which the person has: 
        (i)

    Sole power to vote or to direct the vote   

    See the responses to Item 5 on the attached cover pages.

        (ii)

    Shared power to vote or to direct the vote    

    See the responses to Item 6 on the attached cover pages.

        (iii)

    Sole power to dispose or to direct the disposition of   

    See the responses to Item 7 on the attached cover pages.

        (iv)

    Shared power to dispose or to direct the disposition of   

    See the responses to Item 8 on the attached cover pages.

     
               

     

     

     

    Item 5. Ownership of Five Percent or Less of a Class.
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ¨
     
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
      Not Applicable.
     
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
      Not Applicable.
     
    Item 8. Identification and Classification of Members of the Group.
      Not Applicable.
     
    Item 9. Notice of Dissolution of Group.
      Not Applicable.
       
    Item 10. Certification.
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: February 13, 2024 GATES FRONTIER, LLC (1) 
       
      By: *
        Name: Alan Heuberger (2) 
        Title: Attorney-in-fact for Michael Larson, Manager
     

     

    WILLIAM H. GATES III (1)

         
      By: *
        Name: Alan Heuberger (3) 
        Title: Attorney-in-fact

     

        *By: /s/ Alan Heuberger
        Alan Heuberger

     

     

    (1) This Amendment is being filed jointly by the Reporting Persons pursuant to the Joint Filing Agreement dated September 24, 2021, and included with the signature page to the Reporting Persons’ Schedule 13G with respect to the Issuer filed on September 24, 2021, SEC File No. 005-92092, and incorporated by reference herein.

     

    (2) Duly authorized under Special Limited Power of Attorney appointing Alan Heuberger as attorney-in-fact, dated October 11, 2013, by and on behalf of Michael Larson, filed as Exhibit 99.2 to Gates Frontier, LLC’s Schedule 13G with respect to KiOR, Inc. on October 31, 2013, SEC File No. 005-86313, and incorporated by reference herein.

     

    (3) Duly authorized under Special Limited Power of Attorney appointing Alan Heuberger as attorney-in-fact, dated August 12, 2008, by and on behalf of William H. Gates III, filed as Exhibit 99.3 to Gates Frontier, LLC’s Schedule 13G with respect to KiOR, Inc. on October 31, 2013, SEC File No. 005-86313, and incorporated by reference herein.

     

     

     

    Get the next $RBOT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RBOT

    DatePrice TargetRatingAnalyst
    3/4/2022$16.00 → $7.00Overweight → Neutral
    Piper Sandler
    1/7/2022$16.00Outperform
    Credit Suisse
    12/7/2021$15.00Outperform
    Cowen & Co.
    11/5/2021$15.00Buy
    Canaccord Genuity
    10/18/2021$15.00Buy
    BTIG
    10/7/2021$16.00Overweight
    Piper Sandler
    More analyst ratings

    $RBOT
    SEC Filings

    View All

    SEC Form 10-Q filed by Vicarious Surgical Inc.

    10-Q - Vicarious Surgical Inc. (0001812173) (Filer)

    8/12/25 5:00:50 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Vicarious Surgical Inc. (0001812173) (Filer)

    8/12/25 4:16:02 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Vicarious Surgical Inc. (0001812173) (Filer)

    7/31/25 4:30:50 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vicarious Surgical Reports Second Quarter 2025 Financial Results

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the second quarter ended June 30, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, August 12, 2025. "Leading Vicarious Surgical from its earliest days through key development milestones has been an extraordinary experience. I'm incredibly proud of the foundation we've built. As I move into the role of President, I'm pleased to welcome Stephen as CEO," said Adam Sachs, President, Co-Founder, and Board member. "His depth of experienc

    8/12/25 4:15:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer

    Adam Sachs, Co-Founder, to Remain on as President Vicarious Surgical Inc. (NYSE:RBOT, RBOT WS)) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment of Stephen From as Chief Executive Officer and a member of the Company's Board of Directors (the "Board"), effective August 7, 2025. Adam Sachs, current Chief Executive Officer, Co-Founder, and a member of the Board, will remain with the Company as President, Co-Founder, and a member of the Board in an operational capacity as a member of the Company's leadership team. Mr. From brings over 20 years of leadership in the healthcare and financial

    7/31/25 4:30:00 PM ET
    $KPRX
    $RBOT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties

    Vicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the second quarter ended June 30, 2025 after the market closes on Tuesday, August 12, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing +1 833-470-1428 for domestic callers or +1 404-975-4839 for international callers, using access code: 572850. A live and archived webcast of the event will be available at https://inves

    7/29/25 4:05:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vicarious Surgical downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Vicarious Surgical from Overweight to Neutral and set a new price target of $7.00 from $16.00 previously

    3/4/22 4:51:18 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Credit Suisse initiated coverage on Vicarious Surgical with a new price target

    Credit Suisse initiated coverage of Vicarious Surgical with a rating of Outperform and set a new price target of $16.00

    1/7/22 7:09:02 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Cowen & Co. initiated coverage on Vicarious Surgical with a new price target

    Cowen & Co. initiated coverage of Vicarious Surgical with a rating of Outperform and set a new price target of $15.00

    12/7/21 7:31:51 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Leadership Updates

    Live Leadership Updates

    View All

    Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer

    Ms. Romano brings decades of experience with a strong track record in financial strategy and corporate development Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment of Sarah Romano as Chief Financial Officer (CFO), effective April 1, 2025. Ms. Romano will oversee Vicarious Surgical's financial strategy, leveraging decades of financial leadership experience in capital markets. With exceptional strategic acumen, Ms. Romano has a proven record of driving growth and value creation in public companies, particularly in the h

    3/13/25 8:30:00 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS))), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that Randy Clark has been appointed President effective today, January 29, 2024. As Vicarious Surgical prepares for its next phase of growth following the anticipated finalization of the Vicarious Surgical Version 1.0 System ("V1.0"), the newly established role of President is designed to fortify organizational alignment and focus on the Company's long-term needs and objectives. Reporting to Chief Executive Officer Adam Sachs, Mr. Clark will a

    1/29/24 8:30:00 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Announces Changes to Board of Directors

    Victoria Carr-Brendel, Ph.D. Elected to Board of Directors Tech-Focused Venture Capitalist Phil Liang to Resign Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the appointment of Victoria Carr-Brendel, Ph.D. to the Vicarious Surgical Board of Directors effective today, January 23, 2023. The Company also announced the resignation of technology-focused venture capitalist Phil Liang from the Vicarious Surgical Board of Directors effective as of today. "On behalf of the board, I'd like to thank Phil for his critical guidance and expertise as Vicari

    1/23/23 4:10:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Khalifa Sammy sold $3,946 worth of shares (653 units at $6.04), decreasing direct ownership by 2% to 34,754 units (SEC Form 4)

    4 - Vicarious Surgical Inc. (0001812173) (Issuer)

    8/21/25 7:53:52 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    President Sachs Adam David sold $4,927 worth of shares (817 units at $6.03), decreasing direct ownership by 2% to 49,627 units (SEC Form 4)

    4 - Vicarious Surgical Inc. (0001812173) (Issuer)

    8/21/25 7:53:36 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Director Tang Donald F sold $13,104 worth of shares (2,159 units at $6.07), decreasing direct ownership by 5% to 43,178 units (SEC Form 4)

    4 - Vicarious Surgical Inc. (0001812173) (Issuer)

    8/21/25 7:53:19 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Financials

    Live finance-specific insights

    View All

    Vicarious Surgical Reports Second Quarter 2025 Financial Results

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the second quarter ended June 30, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, August 12, 2025. "Leading Vicarious Surgical from its earliest days through key development milestones has been an extraordinary experience. I'm incredibly proud of the foundation we've built. As I move into the role of President, I'm pleased to welcome Stephen as CEO," said Adam Sachs, President, Co-Founder, and Board member. "His depth of experienc

    8/12/25 4:15:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the second quarter ended June 30, 2025 after the market closes on Tuesday, August 12, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing +1 833-470-1428 for domestic callers or +1 404-975-4839 for international callers, using access code: 572850. A live and archived webcast of the event will be available at https://inves

    7/29/25 4:05:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Reports First Quarter 2025 Financial Results

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, May 12, 2025. "Following years of meticulous work to develop and advance our surgical system and proprietary decoupled actuating technology, we are just a few quarters away from our biggest milestone yet - our first clinical patients. 2025 will be the year Vicarious Surgical evolves into a clinical-stage company and demonstrates the immense value of o

    5/12/25 4:05:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Vicarious Surgical Inc. (Amendment)

    SC 13G/A - Vicarious Surgical Inc. (0001812173) (Subject)

    2/13/24 4:36:42 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Vicarious Surgical Inc. (Amendment)

    SC 13G/A - Vicarious Surgical Inc. (0001812173) (Subject)

    8/15/23 10:28:36 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form SC 13D/A filed by Vicarious Surgical Inc. (Amendment)

    SC 13D/A - Vicarious Surgical Inc. (0001812173) (Subject)

    8/9/23 5:10:57 PM ET
    $RBOT
    Industrial Specialties
    Health Care